NNovartis Read More Novartis (NVS) Has a Potential $3 Billion MS Opportunity — But Investors Face Key Risks2026-09-07 Novartis AG (NYSE:NVS) could be staring at a $3 billion annual peak-sales opportunity in multiple sclerosis (MS) if…
